SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-002493
Filing Date
2024-01-04
Accepted
2024-01-04 16:51:33
Documents
15
Period of Report
2024-01-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638178d8k.htm   iXBRL 8-K 31270
2 EX-1.1 d638178dex11.htm EX-1.1 199754
3 EX-5.1 d638178dex51.htm EX-5.1 8674
7 GRAPHIC g638178g0104132721291.jpg GRAPHIC 2530
  Complete submission text file 0001193125-24-002493.txt   426861

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lbph-20240103.xsd EX-101.SCH 2873
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lbph-20240103_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lbph-20240103_pre.xml EX-101.PRE 11722
9 EXTRACTED XBRL INSTANCE DOCUMENT d638178d8k_htm.xml XML 3480
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 24512873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)